Patents by Inventor Dattatreymurty Bosukonda

Dattatreymurty Bosukonda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TDF-related compounds and analogs thereof
    Patent number: 8410246
    Abstract: The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing, and treating TDF-associated disorders.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: April 2, 2013
    Assignee: Thrasos, Inc.
    Inventors: William D. Carlson, Peter C. Keck, Michael Sworin, Dattatreymurty Bosukonda
  • TDF-related compounds and analogs thereof, analogs and bioactive fragments
    Patent number: 8299212
    Abstract: The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules, which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing, and treating TDF-associated disorders.
    Type: Grant
    Filed: September 20, 2006
    Date of Patent: October 30, 2012
    Assignee: Thrasos Therapeutics, Inc.
    Inventors: William D. Carlson, Peter C. Keck, Dattatreymurty Bosukonda, Philippe Bey
  • SCREENING METHODS FOR BONE MORPHOGENETIC MIMETICS
    Publication number: 20110081662
    Abstract: Disclosed are methods for identifying agents which modulate the activity of bone morphogenetic protein-7. These methods for identifying agents utilize bone morphogenetic protein receptors, specifically the daf-4 receptor, and more specifically the extracellular domain of the daf-4 receptor. Agents identified by the methods are also described as well as compositions comprising the agents and methods of treating a subject using the agents or compositions.
    Type: Application
    Filed: September 3, 2010
    Publication date: April 7, 2011
    Applicant: THRASOS THERAPEUTICS, INC.
    Inventor: Dattatreymurty Bosukonda
  • TDF-RELATED COMPOUNDS AND ANALOGS THEREOF, ANALOGS AND BIOACTIVE FRAGMENTS
    Publication number: 20100209467
    Abstract: The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules, which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing, and treating TDF-associated disorders.
    Type: Application
    Filed: September 20, 2006
    Publication date: August 19, 2010
    Applicant: Thrasos Therapeutics , Inc.
    Inventors: William D. Carlson, Peter C. Keck, Michael Sworin, Dattatreymurty Bosukonda, Kellie Watson, Philippe Bey, Romesh Subramanian
  • Tdf-related compounds and analogs thereof
    Publication number: 20100015150
    Abstract: The present invention relates generally to tissue differentiation factor (TDF) analogs. More specifically, the invention relates to structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like receptors. The invention further relates to methods of detecting, preventing, and treating TDF-associated disorders.
    Type: Application
    Filed: June 17, 2005
    Publication date: January 21, 2010
    Applicant: Thrasos Therapeutics, Inc.
    Inventors: William D. Carlson, Peter C. Keck, Michael Sworin, Dattatreymurty Bosukonda
  • Screening method for bone morphogenetic mimetics
    Publication number: 20090124537
    Abstract: Disclosed are methods for identifying agents which modulate the activity of bone morphogenetic protein-7. These methods for identifying agents utilize bone morphogenetic protein receptors, specifically the daf-4 receptor, and more specifically the extracellular domain of the daf-4 receptor. Agents identified by the methods are also described as well as compositions comprising the agents and methods of treating a subject using the agents or compositions.
    Type: Application
    Filed: June 6, 2008
    Publication date: May 14, 2009
    Applicant: Thrasos, Inc.
    Inventor: Dattatreymurty Bosukonda
  • Screening methods for bone morphogenetic mimetics
    Publication number: 20040009532
    Abstract: Disclosed are methods for identifying agents which modulate the activity of bone morphogenetic protein-7. These methods for identifying agents utilize bone morphogenetic protein receptors, specifically the daf-4 receptor, and more specifically the extracellular domain of the daf-4 receptor. Agents identified by the methods are also described as well as compositions comprising the agents and methods of treating a subject using the agents or compositions.
    Type: Application
    Filed: May 5, 2003
    Publication date: January 15, 2004
    Applicant: Thrasos, Inc.
    Inventor: Dattatreymurty Bosukonda